EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advancing Renal Amyloidosis Care: The Role of Modern Diagnostic Techniques with the Potential of Enhancing Patient Outcomes

Charlotte Delrue, Amélie Dendooven, Annelore Vandendriessche, Reinhart Speeckaert iD, Sander De Bruyne iD, Marijn M Speeckaert iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25115875 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Charlotte Delrue und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Ghent University Hospital, 9000 Ghent, Belgium. Hauptthemen laut MEDLINE: Amyloidosis, Kidney Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal amyloidosis is a set of complex disorders characterized by the deposition of amyloid proteins in the kidneys, which causes gradual organ damage and potential kidney failure. Recent developments in diagnostic methods, particularly mass spectrometry and proteome profiling, have greatly improved the accuracy of amyloid typing, which is critical for disease management. These technologies provide extensive insights into the specific proteins involved, allowing for more targeted treatment approaches and better patient results. Despite these advances, problems remain, owing to the heterogeneous composition of amyloid proteins and the varying efficacy of treatments based on amyloid type. Access to sophisticated diagnostics and therapy varies greatly, highlighting the global difference in renal amyloidosis management. Future research is needed to investigate next-generation sequencing and gene-editing technologies, like clustered regularly interspaced short palindromic repeats (CRISPR), which promise more profound insights into the genetic basis of amyloidosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmyloidosisKidney DiseasesHumansProteomicsMass Spectrometry

Stichwörter der Autor:innen

amyloidosisimmunofluorescenceimmunohistochemistrymass spectrometrynext-generation sequencingproteomics

Autor:innen und Institutionen

  • Department of Nephrology, Ghent University Hospital, 9000 Ghent, Belgium.
  • Department of Pathology, Ghent University Hospital, 9000 Ghent, Belgium.
  • Faculty of Medicine, University of Antwerp, 2610 Wilrijk, Belgium.
  • Department of Dermatology, Ghent University Hospital, 9000 Ghent, Belgium.
  • Department of Laboratory Medicine, Ghent University Hospital, 9000 Ghent, Belgium.
  • Research Foundation-Flanders (FWO), 1000 Brussels, Belgium.

ORCID-Profile: Reinhart Speeckaert, Sander De Bruyne, Marijn M Speeckaert

Zitieren

APA

Delrue, C., Dendooven, A., Vandendriessche, A., Speeckaert, R., De Bruyne, S., & Speeckaert, M. M. (2024). Advancing Renal Amyloidosis Care: The Role of Modern Diagnostic Techniques with the Potential of Enhancing Patient Outcomes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25115875

Vancouver

Delrue C, Dendooven A, Vandendriessche A, Speeckaert R, De Bruyne S, Speeckaert MM. Advancing Renal Amyloidosis Care: The Role of Modern Diagnostic Techniques with the Potential of Enhancing Patient Outcomes. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25115875

BibTeX
@article{Delrue2024,
  author = {Delrue, Charlotte and Dendooven, Amélie and Vandendriessche, Annelore and Speeckaert, Reinhart and De Bruyne, Sander and Speeckaert, Marijn M},
  title = {Advancing Renal Amyloidosis Care: The Role of Modern Diagnostic Techniques with the Potential of Enhancing Patient Outcomes},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25115875}
}
Kostenlos starten →